Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer.
about
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.Dose considerations for anti-cancer drugs in metastatic prostate cancer.A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.Comment on: "Modeling the Relationship between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer".
P2860
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@en
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@nl
type
label
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@en
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@nl
prefLabel
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@en
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@nl
P2093
P2860
P1476
Modeling the Relationship Betw ...... ion-Resistant Prostate Cancer.
@en
P2093
An Vermeulen
Charles J Ryan
Italo Poggesi
Kim Stuyckens
Margaret K Yu
Matthew R Smith
Partha Nandy
Peter De Porre
Thomas W Griffin
P2860
P2888
P356
10.1007/S40262-016-0425-0
P577
2016-06-21T00:00:00Z